Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Gordon McKee
"Status Quo Is Not An Option": Phase 2 Consultation Paper Published For Ontario Civil Rules Review
On April 1, 2025, the Civil Rules Review (CRR) Working Group published its Phase 2 Consultation Paper (Paper) outlining its proposed framework for revamping Ontario's Rules of Civil Procedure (Rules). If implemented, this new framework will result in significant changes to the civil litigation process in Ontario.
“Status Quo Is Not an Option”: Phase 2 Consultation Paper Published for Ontario Civil Rules Review | JD Supra
On April 1, 2025, the Civil Rules Review (CRR) Working Group published its Phase 2 Consultation Paper (Paper) outlining its proposed framework for revamping Ontario’s Rules of Civil Procedure (Rules). If implemented, this new framework will result in significant changes to the civil litigation process in Ontario.
“Status Quo Is Not an Option”: Phase 2 Consultation Paper Published for Ontario Civil Rules Review | Blakes
On April 1, 2025, the Civil Rules Review (CRR) Working Group published its Phase 2 Consultation Paper (Paper) outlining its proposed framework for revamping Ontario’s Rules of Civil Procedure (Rules). If implemented, this new framework will result in significant changes to the civil litigation process in Ontario.
Canadian Court Strikes Plaintiffs' Expert Evidence, Denies Certification Of Pharmaceutical Class Action - Class Actions - Canada
The Canadian Legal Information Institute recently published an overlooked but important class action decision of the Saskatchewan Court of King's Bench (Court) in Graham et al. v. Hoffmann-La Roche Limited et al. (Graham). The Court struck the plaintiffs' expert opinion on the alleged link between a well-known medicine for severe acne (Medicine) and inflammatory bowel disease (IBD). The Court also refused to certify the proposed national class action.
Canadian Court Strikes Plaintiffs’ Expert Evidence, Denies Certification of Pharmaceutical Class Act | JD Supra
The Canadian Legal Information Institute recently published an overlooked but important class action decision of the Saskatchewan Court of King’s Bench (Court) in Graham et al. v. Hoffmann-La Roche Limited et al. (Graham). The Court struck the plaintiffs’ expert opinion on the alleged link between a well-known medicine for severe acne (Medicine) and inflammatory bowel disease (IBD). The Court also refused to certify the proposed national class action.
Canadian Court Strikes Plaintiffs’ Expert Evidence, Denies Certification of Pharmaceutical Class Act | Blakes
The Canadian Legal Information Institute recently published an overlooked but important class action decision of the Saskatchewan Court of King’s Bench (Court) in Graham et al. v. Hoffmann-La Roche Limited et al. (Graham). The Court struck the plaintiffs’ expert opinion on the alleged link between a well-known medicine for severe acne (Medicine) and inflammatory bowel disease (IBD). The Court also refused to certify the proposed national class action.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Gordon
Contact Gordon, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack